While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized.
The aim of our project is to develop, implement and establish evidentiary standards and methods to address the data and evidentiary needs of regulatory authorities and health technology assessment (HTA) bodies towards a more efficient use of RWD for the development, registration and assessment of medicinal products in Europe.
Company Details
- Founded
- 2023
- Address
- Groningen, Nl
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- real-world evidence, real-world data, registries, regulatory decision making, health technology assessment.
- HQ
- Groningen
More-Europa Questions
More-Europa's website is https://umcgresearch.org/w/more-europa
More-Europa's LinkedIn profile is https://nl.linkedin.com/company/more-europa
More-Europa's industry is
Research Services
More-Europa's top competitors are
Eosc-Life,
Real4reg,
Quinten Health,
Eosc-Everse,
Escape,
Panosc,
Efibio,
Oncovalue,
Quinten,
See Breathe.
More-Europa's categories are Research Services
More-Europa's founding year is 2023
